p300/CBP and cancer
- PMID: 15156177
- DOI: 10.1038/sj.onc.1207118
p300/CBP and cancer
Abstract
p300 and cyclic AMP response element-binding protein (CBP) are adenoviral E1A-binding proteins involved in multiple cellular processes, and function as transcriptional co-factors and histone acetyltransferases. Germline mutation of CBP results in Rubinstein-Taybi syndrome, which is characterized by an increased predisposition to childhood malignancies. Furthermore, somatic mutations of p300 and CBP occur in a number of malignancies. Chromosome translocations target CBP and, less commonly, p300 in acute myeloid leukemia and treatment-related hematological disorders. p300 mutations in solid tumors result in truncated p300 protein products or amino-acid substitutions in critical protein domains, and these are often associated with inactivation of the second allele. A mouse model confirms that p300 and CBP function as suppressors of hematological tumor formation. The involvement of these proteins in critical tumorigenic pathways (including TGF-beta, p53 and Rb) provides a mechanistic route as to how their inactivation could result in cancer.
Similar articles
-
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.Nature. 1996 Jul 25;382(6589):319-24. doi: 10.1038/382319a0. Nature. 1996. PMID: 8684459
-
CBP/p300 histone acetyl-transferase activity is important for the G1/S transition.Oncogene. 2000 May 11;19(20):2430-7. doi: 10.1038/sj.onc.1203562. Oncogene. 2000. PMID: 10828885
-
Developmentally regulated expression of the transcriptional cofactors/histone acetyltransferases CBP and p300 during mouse embryogenesis.Int J Dev Biol. 1999 Sep;43(6):487-94. Int J Dev Biol. 1999. PMID: 10610021
-
The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease.Histol Histopathol. 2002 Apr;17(2):657-68. doi: 10.14670/HH-17.657. Histol Histopathol. 2002. PMID: 11962765 Review.
-
p300 and CBP as transcriptional regulators and targets of oncogenic events.Biol Chem. 1996 Nov;377(11):685-8. Biol Chem. 1996. PMID: 8960368 Review.
Cited by
-
The adenovirus E1A oncoprotein N-terminal transcriptional repression domain enhances p300 autoacetylation and inhibits histone H3 Lys18 acetylation.Genes Cancer. 2015 Jan;6(1-2):30-7. doi: 10.18632/genesandcancer.47. Genes Cancer. 2015. PMID: 25821559 Free PMC article.
-
Acetylation modulates the Fanconi anemia pathway by protecting FAAP20 from ubiquitin-mediated proteasomal degradation.J Biol Chem. 2020 Oct 2;295(40):13887-13901. doi: 10.1074/jbc.RA120.015288. Epub 2020 Aug 6. J Biol Chem. 2020. PMID: 32763975 Free PMC article.
-
Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.Med Oncol. 2023 Nov 8;40(12):351. doi: 10.1007/s12032-023-02222-3. Med Oncol. 2023. PMID: 37940725
-
Histone Modifications and Cancer.Cold Spring Harb Perspect Biol. 2016 Apr 1;8(4):a019521. doi: 10.1101/cshperspect.a019521. Cold Spring Harb Perspect Biol. 2016. PMID: 27037415 Free PMC article. Review.
-
Epigenetic reprogramming in cancer.Science. 2013 Mar 29;339(6127):1567-70. doi: 10.1126/science.1230184. Science. 2013. PMID: 23539597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous